期刊
EXPERT REVIEW OF CLINICAL IMMUNOLOGY
卷 12, 期 3, 页码 233-236出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/1744666X.2016.1112271
关键词
inflammatory bowel diseases; immunology; cytokines; gut homing; personalized medicine
类别
Fundamental insights into the pathogenesis of inflammatory bowel diseases (IBD) have led to the development of new therapies and lots of experimental compounds in the pipeline. Our treatment of IBD is therefore constantly evolving. In this editorial, we postulate that bi- or even polyspecific therapy will be an important mainstay of future IBD treatment. Moreover, we highlight some promising new therapeutic concepts currently under investigation and point at the outstanding and growing importance of personalized medicine to assign drugs from the increasing pool of options to the individual patient.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据